These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2453896)
21. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis. Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597 [TBL] [Abstract][Full Text] [Related]
23. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768 [TBL] [Abstract][Full Text] [Related]
24. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. Holloway SE; Beck AW; Shivakumar L; Shih J; Fleming JB; Brekken RA Ann Surg Oncol; 2006 Aug; 13(8):1145-55. PubMed ID: 16791450 [TBL] [Abstract][Full Text] [Related]
25. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function. Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244 [TBL] [Abstract][Full Text] [Related]
26. Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade. Li J; Huang S; Armstrong EA; Fowler JF; Harari PM Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1477-85. PubMed ID: 16029810 [TBL] [Abstract][Full Text] [Related]
28. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254 [TBL] [Abstract][Full Text] [Related]
29. RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization. Wang W; Wu F; Fang F; Tao Y; Yang L Cancer Sci; 2008 Oct; 99(10):2012-8. PubMed ID: 19016761 [TBL] [Abstract][Full Text] [Related]
30. Tumor angiogenesis suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via peroxisome proliferator-activated receptor gamma. Tsuzuki T; Kawakami Y Carcinogenesis; 2008 Apr; 29(4):797-806. PubMed ID: 18174233 [TBL] [Abstract][Full Text] [Related]
31. Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo. Soh EY; Eigelberger MS; Kim KJ; Wong MG; Young DM; Clark OH; Duh QY Surgery; 2000 Dec; 128(6):1059-65;discussion 1065-6. PubMed ID: 11114643 [TBL] [Abstract][Full Text] [Related]
32. Effects of X irradiation on angiogenesis. Prionas SD; Kowalski J; Fajardo LF; Kaplan I; Kwan HH; Allison AC Radiat Res; 1990 Oct; 124(1):43-9. PubMed ID: 1700450 [TBL] [Abstract][Full Text] [Related]
33. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Brantley DM; Cheng N; Thompson EJ; Lin Q; Brekken RA; Thorpe PE; Muraoka RS; Cerretti DP; Pozzi A; Jackson D; Lin C; Chen J Oncogene; 2002 Oct; 21(46):7011-26. PubMed ID: 12370823 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. Beebe JS; Jani JP; Knauth E; Goodwin P; Higdon C; Rossi AM; Emerson E; Finkelstein M; Floyd E; Harriman S; Atherton J; Hillerman S; Soderstrom C; Kou K; Gant T; Noe MC; Foster B; Rastinejad F; Marx MA; Schaeffer T; Whalen PM; Roberts WG Cancer Res; 2003 Nov; 63(21):7301-9. PubMed ID: 14612527 [TBL] [Abstract][Full Text] [Related]
35. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
36. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990 [TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor. Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248 [TBL] [Abstract][Full Text] [Related]
38. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity. McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479 [TBL] [Abstract][Full Text] [Related]
39. Arrhenius relationships from the molecule and cell to the clinic. Dewey WC Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695 [TBL] [Abstract][Full Text] [Related]